Shortlist

EV/EBIT of 7.8 against a Healthcare median of 23.1 — 66% below peers. Free cash flow yield 12.7%. Trading 70% below its all-time high set 2000-08-25.

At the Healthcare median EV/EBIT of 23.1 instead of its current 7.8, and with earnings unchanged, the equity would be worth about 207% more. That is the size of the gap, not a forecast that it closes.

• ROIC 760% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 48% over three years
• net debt 0.5x EBITDA — balance sheet not forcing anything

Consensus strong buy from 11 analysts, mean target 20.82 USD, 109% above the current price. No revision activity in the last quarter.

Targets spread 96% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Implied upside of 109% is unusually high. The evidence runs the other way here: stocks with the most optimistic targets tend to underperform, because the optimism bias is real and priced-in slowly. Read this as a caution, not an opportunity.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 10.6 against a Industrials median of 21.1 — 50% below peers. Free cash flow yield 8.2%.

At the Industrials median EV/EBIT of 21.1 instead of its current 10.6, and with earnings unchanged, the equity would be worth about 92% more. That is the size of the gap, not a forecast that it closes.

• ROIC 112% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 8/9 — accounts improving year on year
• revenue compounding at 23% over three years
• net debt -0.7x EBITDA — balance sheet not forcing anything

Consensus strong buy from 8 analysts, mean target 89.12 USD, 40% above the current price. No revision activity in the last quarter.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 12.3 against a Consumer Cyclical median of 18.2 — 32% below peers. Free cash flow yield 8.8%. Trading 40% below its all-time high set 2018-09-27.

At the Consumer Cyclical median EV/EBIT of 18.2 instead of its current 12.3, and with earnings unchanged, the equity would be worth about 48% more. That is the size of the gap, not a forecast that it closes.

• ROIC 51% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• net debt 0.0x EBITDA — balance sheet not forcing anything
• Altman Z 10.0 — outside the distress zone

Consensus buy from 12 analysts, mean target 41.50 USD, 23% above the current price. No revision activity in the last quarter.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 11.8 against a Technology median of 27.3 — 57% below peers. Free cash flow yield 9.3%. Trading 61% below its all-time high set 2021-11-19.

At the Technology median EV/EBIT of 27.3 instead of its current 11.8, and with earnings unchanged, the equity would be worth about 132% more. That is the size of the gap, not a forecast that it closes.

• ROIC 63% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 11% over three years
• net debt 0.0x EBITDA — balance sheet not forcing anything

Consensus hold from 34 analysts, mean target 270.61 USD, 2% above the current price. Revisions over the last quarter have been net negative — the sell side is marking this down.

Targets spread 70% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 0.4 against a Technology median of 27.3 — 99% below peers. Free cash flow yield 184.7%. Trading 86% below its all-time high set 2000-03-03.

At the Technology median EV/EBITDA of 18.9 instead of its current 0.3, and with earnings unchanged, the equity would be worth about n/a more. That is the size of the gap, not a forecast that it closes.

• ROIC 33% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 8/9 — accounts improving year on year
• net debt -0.3x EBITDA — balance sheet not forcing anything
• operating margin 17%

mean target 9.67 SEK, 4% below the current price. No revision activity in the last quarter.

Targets spread 35% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Trading 4% above the consensus target — the sell side thinks it is expensive.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 7.0 against a Consumer Defensive median of 17.0 — 59% below peers. Free cash flow yield 13.8%. Trading 50% below its all-time high set 2004-04-21.

At the Consumer Defensive median EV/EBIT of 17.0 instead of its current 7.0, and with earnings unchanged, the equity would be worth about 107% more. That is the size of the gap, not a forecast that it closes.

• ROIC 35% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 7% over three years
• net debt -1.9x EBITDA — balance sheet not forcing anything

mean target 44.00 USD, 33% above the current price. No revision activity in the last quarter.

Only 1 analyst estimate(s) — too few for a consensus to mean much.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 4.6 against a Financial Services median of 8.7 — 47% below peers. Free cash flow yield 23.0%. Trading 57% below its all-time high set 2025-06-09.

At the Financial Services median EV/EBIT of 8.7 instead of its current 4.6, and with earnings unchanged, the equity would be worth about 47% more. That is the size of the gap, not a forecast that it closes.

• ROIC 144% — still earning above a plausible cost of capital
• free cash flow positive
• revenue compounding at 30% over three years
• net debt -4.0x EBITDA — balance sheet not forcing anything
• Altman Z 13.2 — outside the distress zone

Consensus buy from 14 analysts, mean target 48.43 USD, 49% above the current price. No revision activity in the last quarter.

Targets spread 118% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

P/E of 2.3 against a Communication Services median of 15.3 — 85% below peers.

No usable re-rating gap: the multiple is at or above its sector median, or the inputs were missing.

• ROIC 692% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 5% over three years
• net debt -4.1x EBITDA — balance sheet not forcing anything

Consensus strong buy from 32 analysts, mean target 161.33 CNY, 35% above the current price. No revision activity in the last quarter.

Targets spread 42% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 18.3 against a Technology median of 27.3 — 33% below peers. Free cash flow yield 6.5%. Trading 58% below its all-time high set 2025-07-30.

At the Technology median EV/EBIT of 27.3 instead of its current 18.3, and with earnings unchanged, the equity would be worth about 50% more. That is the size of the gap, not a forecast that it closes.

• ROIC 19% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 9/9 — accounts improving year on year
• revenue compounding at 14% over three years
• net debt 0.4x EBITDA — balance sheet not forcing anything

Consensus buy from 33 analysts, mean target 446.02 USD, 34% above the current price. Revisions over the last quarter have been net negative — the sell side is marking this down.

Targets spread 150% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 6.0 against a Consumer Defensive median of 17.0 — 65% below peers. Free cash flow yield 6.6%. Trading 42% below its all-time high set 2025-04-23.

At the Consumer Defensive median EV/EBIT of 17.0 instead of its current 6.0, and with earnings unchanged, the equity would be worth about 252% more. That is the size of the gap, not a forecast that it closes.

• ROIC 19% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• net debt 1.3x EBITDA — balance sheet not forcing anything
• Altman Z 3.4 — outside the distress zone

Consensus hold from 7 analysts, mean target 33.64 USD, 10% above the current price. No revision activity in the last quarter.

Targets spread 42% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 25.5 against a Technology median of 27.3 — 7% below peers. Free cash flow yield 5.2%. Trading 36% below its all-time high set 2021-08-25.

At the Technology median EV/EBIT of 27.3 instead of its current 25.5, and with earnings unchanged, the equity would be worth about 7% more. That is the size of the gap, not a forecast that it closes.

• ROIC 40% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 13% over three years
• net debt 0.1x EBITDA — balance sheet not forcing anything

Consensus strong buy from 34 analysts, mean target 314.57 USD, 44% above the current price. No revision activity in the last quarter.

Targets spread 75% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 9.9 against a Technology median of 27.3 — 64% below peers. Free cash flow yield 12.9%. Trading 37% below its all-time high set 2026-06-03.

At the Technology median EV/EBIT of 27.3 instead of its current 9.9, and with earnings unchanged, the equity would be worth about 153% more. That is the size of the gap, not a forecast that it closes.

• ROIC 30% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• net debt -1.4x EBITDA — balance sheet not forcing anything
• Altman Z 11.6 — outside the distress zone

mean target 165.00 USD, 46% above the current price. No revision activity in the last quarter.

Targets spread 42% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.